Stay updated on PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.

Latest updates to the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a government funding status notice (NIH open; cc.nih.gov and opm.gov links) and the revision tag updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check10 days agoChange DetectedAdded UI/metadata changes include a 'Show glossary' option, new labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and 'No FEAR Act Data'; the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA minor version update from v3.3.3 to v3.3.4 is shown; no visible changes to the study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedGuangdong has been added to the Locations section as a new trial site. This update expands the study's geographic reach and provides participation details for the new site.SummaryDifference0.2%

- Check67 days agoChange DetectedThe page revision label was updated to v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

- Check75 days agoChange DetectedA new note indicates PubMed publications are automatically filled and may not relate to the study, and the revision stamp updated to v3.3.1, replacing the older v3.2.0 wording.SummaryDifference0.1%

Stay in the know with updates to PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition & Ablation for Advanced HCC Clinical Trial page.